Cryofocus Medtech (Shanghai) Co., Ltd.

SEHK:6922 Stock Report

Market Cap: HK$2.4b

Cryofocus Medtech (Shanghai) Management

Management criteria checks 1/4

Cryofocus Medtech (Shanghai)'s CEO is Jun Zhu, appointed in Oct 2020, has a tenure of 3.5 years. total yearly compensation is CN¥12.01M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth HK$14.67M. The average tenure of the management team and the board of directors is 3.5 years and 2.6 years respectively.

Key information

Jun Zhu

Chief executive officer

CN¥12.0m

Total compensation

CEO salary percentage18.9%
CEO tenure3.5yrs
CEO ownership0.6%
Management average tenure3.5yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate

Jan 10
We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate

Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans

Oct 03
Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans

Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth

May 30
Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Jun Zhu's remuneration changed compared to Cryofocus Medtech (Shanghai)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CN¥97m

Jun 30 2023n/an/a

-CN¥113m

Mar 31 2023n/an/a

-CN¥113m

Dec 31 2022CN¥12mCN¥2m

-CN¥112m

Dec 31 2021CN¥7mCN¥2m

-CN¥102m

Dec 31 2020CN¥850kCN¥836k

-CN¥137m

Compensation vs Market: Jun's total compensation ($USD1.66M) is above average for companies of similar size in the Hong Kong market ($USD404.50K).

Compensation vs Earnings: Jun's compensation has increased whilst the company is unprofitable.


CEO

Jun Zhu (48 yo)

3.5yrs

Tenure

CN¥12,013,000

Compensation

Mr. Jun Zhu serves as Consultant at Proxima Ventures, where he was previously an External Consultant. Mr. Zhu serves as General Manager at Cryofocus Medtech (Shanghai) Co., Ltd. since October 2020 and ser...


Leadership Team

NamePositionTenureCompensationOwnership
Kejian Li
Executive Chairman of the Board11.1yrsno datano data
Jun Zhu
GM & Executive Director3.5yrsCN¥12.01m0.62%
CN¥ 14.7m
Wei Liu
CFO, Joint Company Secretary & Executive Director3.5yrsno datano data
Kuiwen Zhao
Technical Director and R&D Manager5.1yrsno datano data
Jihong Qu
Chief Medical Officer2.1yrsno datano data
Zhimin Chen
Executive Vice President of Ningbo SensCure7.3yrsno datano data
Wai Yan Leung
Joint Company Secretay2.3yrsno datano data
Yuepeng Diao
Deputy Vice President10.6yrsno datano data

3.5yrs

Average Tenure

40yo

Average Age

Experienced Management: 6922's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kejian Li
Executive Chairman of the Board11.1yrsno datano data
Jun Zhu
GM & Executive Director3.3yrsCN¥12.01m0.62%
CN¥ 14.7m
Wei Liu
CFO, Joint Company Secretary & Executive Directorless than a yearno datano data
Hsien Tse Liang
Independent Non-Executive Director2.3yrsno datano data
Dayong Gao
Independent Non-Executive Director2.3yrsno datano data
Shiwen Lv
Non-Executive Director9.8yrsno data9.15%
CN¥ 217.8m
Haorong Zhu
Supervisor3.8yrsno datano data
Zheng Qin
Independent Non-Executive Director2.3yrsno datano data
Chunsheng Zhao
Non-Executive Director2.8yrsno datano data
Henan Hu
Independent Non-Executive Director1.4yrsno datano data
Junkang Qiu
Supervisor5.4yrsno datano data
Jiawei Li
Chairperson of the Board of Supervisorsless than a yearno datano data

2.6yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 6922's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.